NHS National Framework Agreement for the supply of Recombinant Factor X and Porcine Factor VIII for the treatment of bleeding disorders
This is a contract result notice, not an open opportunity. Details from the official award data.
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
NHS National framework agreement for the supply of Recombinant Factor X and Porcine Factor VIII for the treatment of bleeding disorders.
The framework will commence on 1.7.2016 to 31.6.2017 with options to extend for up to a further 36 months.
Please refer to the Invitation to offer, Document No.05d for a list of the Participating Authorities.
What the supplier must deliver
NHS National framework agreement for the supply
NHS National framework agreement for the supply of Recombinant Factor X and Porcine Factor VIII for the treatment of bleeding disorders.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at COMMERCIAL MEDICINES UNIT, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- 383b2dcb-3a15-43e0-883b-4cf690867a21
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CM/PHS/16/5502
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
COMMERCIAL MEDICINES UNIT’s tender network
Assembling the network…